UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The “Silent” Global Burden of Congenital Cytomegalovirus

Clinical Microbiology Reviews, 2013-01, Vol.26 (1), p.86-102

2013

Volltextzugriff (PDF)

A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus

The New England journal of medicine, 2014-04, Vol.370 (14), p.1316-1326

2014

Volltextzugriff (PDF)

Clinical Utility of Viral Load in Management of Cytomegalovirus Infection after Solid Organ Transplantation

Clinical Microbiology Reviews, 2013-10, Vol.26 (4), p.703-727

2013

Volltextzugriff (PDF)

Infection in Solid-Organ Transplant Recipients

The New England journal of medicine, 2007-12, Vol.357 (25), p.2601-2614

Fishman, Jay A

2007

Volltextzugriff (PDF)

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Transplantation, 2010-04, Vol.89 (7), p.779-795

2010

Volltextzugriff (PDF)

Vaccine Prevention of Maternal Cytomegalovirus Infection

The New England journal of medicine, 2009-03, Vol.360 (12), p.1191-1199

2009

Volltextzugriff (PDF)

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2014-05, Vol.370 (19), p.1781-1789

2014

Volltextzugriff (PDF)

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

American journal of transplantation, 2010-05, Vol.10 (5), p.1228-1237

2010

Volltextzugriff (PDF)

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2013-09, Vol.369 (13), p.1227-1236

2013

Volltextzugriff (PDF)

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet infectious diseases, 2012-04, Vol.12 (4), p.290-299

2012

Volltextzugriff (PDF)

High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

The Journal of infectious diseases, 2014-02, Vol.209 (4), p.557-561

2014

Volltextzugriff (PDF)

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

The New England journal of medicine, 2005-09, Vol.353 (13), p.1350-1362

2005

Volltextzugriff (PDF)

New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation

Drugs (New York, N.Y.), 2010-05, Vol.70 (8), p.965-981

2010

Volltextzugriff (PDF)

Pretransplant Immediately Early‐1‐Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation

American journal of transplantation, 2013-07, Vol.13 (7), p.1793-1805

2013

Volltextzugriff (PDF)

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

American journal of transplantation, 2007-09, Vol.7 (9), p.2106-2113

2007

Volltextzugriff (PDF)

Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation

The Lancet infectious diseases, 2012-10, Vol.12 (10), p.790-798

Griffiths, Paul D, Prof

2012

Volltextzugriff (PDF)

Human Cytomegalovirus and Kidney Transplantation: A Clinician's Update

American journal of kidney diseases, 2011-07, Vol.58 (1), p.118-126

2011

Volltextzugriff (PDF)

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

The Lancet infectious diseases, 2011-04, Vol.11 (4), p.284-292

2011

Volltextzugriff (PDF)

Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory Committee

Clinical infectious diseases, 2004-07, Vol.39 (2), p.233-239

2004

Volltextzugriff (PDF)

Congenital cytomegalovirus (CMV) epidemiology and awareness

Journal of clinical virology, 2009-12, Vol.46, p.S6-S10

Cannon, Michael J

2009

Volltextzugriff (PDF)

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

Clinical infectious diseases, 2008-03, Vol.46 (6), p.840-846

2008

Volltextzugriff (PDF)

Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital

Journal of clinical virology, 2009-12, Vol.46, p.S49-S53

2009

Volltextzugriff (PDF)

Preformed Frequencies of Cytomegalovirus (CMV)–Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients

Clinical infectious diseases, 2014-12, Vol.59 (11), p.1537-1545

2014

Volltextzugriff (PDF)

Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients

Transplantation, 2012-06, Vol.93 (11), p.1075-1085

2012

Volltextzugriff (PDF)

1 – 25 von 1.001

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTransplantation Proceedings

ThemaHumans

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(970)
Mit Volltextzugriff
(693)

Publikationsform

Artikel
(1.001)

Sprache

Englisch
(1.001)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(1.001)
Science & Technology
(926)
Life Sciences & Biomedicine
(924)
Cytomegalovirus Infections - Prevention & Control
(744)
Female
(576)
Cytomegalovirus
(538)
Adult
(533)
Male
(524)
Middle Aged
(440)
Transplantation
(422)
Infectious Diseases
(397)
Immunology
(361)
Antiviral Agents - Therapeutic Use
(324)
Pharmacology. Drug Treatments
(298)
Adolescent
(278)
Viral Diseases
(276)
Ganciclovir - Therapeutic Use
(269)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(239)

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.001)
Journals@Ovid
(754)
EZB Electronic Journals Library
(470)
Ingenta
(312)
Single Online Journals
(304)
Wiley Journals
(185)
Wiley Online Library
(172)
Access via ScienceDirect (Elsevier)
(136)
Oxford University Press Journals Current
(124)
Oxford Journals 2020 Medicine
(122)
IngentaConnect Journals
(120)
Nexis Uni
(100)
JSTOR All Journals
(98)
Nature
(97)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(85)
Springer journals
(63)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(49)
Taylor & Francis Online
(16)
Access via Taylor & Francis
(15)
Taylor & Francis Online Single Subscriptions
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The “Silent” Global Burden of Congenital Cytomegalovirus

A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus

Clinical Utility of Viral Load in Management of Cytomegalovirus Infection after Solid Organ Transplantation

Infection in Solid-Organ Transplant Recipients

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

Vaccine Prevention of Maternal Cytomegalovirus Infection

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation

Pretransplant Immediately Early‐1‐Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation

Human Cytomegalovirus and Kidney Transplantation: A Clinician's Update

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory Committee

Congenital cytomegalovirus (CMV) epidemiology and awareness

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital

Preformed Frequencies of Cytomegalovirus (CMV)–Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients

Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients

Aktive Filter

Suchergebnisse filtern